Induction of Clinical Response Using Rifaximin in Crohn's Disease

This study is currently recruiting participants.
Verified June 2012 by University of Washington
Sponsor:
Collaborator:
Salix Pharmaceuticals
Information provided by (Responsible Party):
Scott Lee, University of Washington
ClinicalTrials.gov Identifier:
NCT00603616
First received: January 16, 2008
Last updated: June 13, 2012
Last verified: June 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2012
  Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)